Literature DB >> 7367733

Estrogen receptor status and the disease-free interval in breast cancer.

J C Allegra, M E Lippman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7367733     DOI： 10.1007/978-3-642-81406-8_6

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  8 in total

Review 1.  Regulation of estrogen receptor expression.

Authors:  M B Martin; M Saceda; P Garcia-Morales; M M Gottardis
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

2.  Studies on estradiol receptors in human mammary carcinomas.

Authors:  M J Duffy; M O'Connell; L McDonnell; C E Connolly; B Cantwell; J J Fennelly; R Conroy
Journal:  Ir J Med Sci       Date:  1984-11       Impact factor: 1.568

3.  p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.

Authors:  Crystal E Berger; Yingjuan Qian; Gang Liu; Hongwu Chen; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

4.  Prognostic value of estrogen and progesterone receptors in primary breast cancer.

Authors:  S Saez; F Cheix; B Asselain
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

5.  Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer.

Authors:  A Bertuzzi; M G Daidone; G Di Fronzo; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

6.  Hormone receptors and obesity in Japanese women with breast cancer.

Authors:  K Kuno; A Fukami; M Hori; F Kasumi
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

Review 7.  Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysis.

Authors:  Jill Brook Hervik; Trine Stub
Journal:  Breast Cancer Res Treat       Date:  2016-10-05       Impact factor: 4.872

8.  Status of HER-2/neu receptors and Ki-67 in breast cancer of Indian women.

Authors:  Rajeev Singhai; Vw Patil; Av Patil
Journal:  Int J Appl Basic Med Res       Date:  2011-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.